Benjamin A. Hertzog
Plus aucun poste en cours
Profil
Benjamin A.
Hertzog is a professional who has held several positions in different firms.
He was the President & Chief Executive Officer at Procyrion, Inc. and a Director at Kardia Therapeutics, Inc. He was also a Vice President at BCM Technologies, Inc. and a Senior Vice President-Business Development at Advanced Health Education Center Ltd.
Hertzog has an undergraduate degree from Trinity University and a doctorate from Brown University.
Anciens postes connus de Benjamin A. Hertzog
| Sociétés | Poste | Fin |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Private Equity Investor | 01/01/2006 |
Procyrion, Inc.
 Procyrion, Inc. Medical SpecialtiesHealth Technology Procyrion, Inc. manufactures medical devices. The firm develops percutaneous circulatory assist device intended to treat chronic heart failure. Its product Aortix is a catheter deployed circulatory assist device for the millions of heart failure patients who are too sick for medication alone. The company was founded by Reynolds M. Delgado III in 2005 and is headquartered in Houston, TX. | Directeur Général | - |
Advanced Health Education Center Ltd.
 Advanced Health Education Center Ltd. Miscellaneous Commercial ServicesCommercial Services Advanced Health Education Center Ltd. provides continuing education for healthcare professionals in the imaging sciences. The firm's services include community service and professional news, staffing, personal and elder care services and mammography. The company was founded in 1988 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Kardia Therapeutics, Inc.
 Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Formation de Benjamin A. Hertzog
| Trinity University | Undergraduate Degree |
| Brown University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Procyrion, Inc.
Procyrion, Inc. Medical SpecialtiesHealth Technology Procyrion, Inc. manufactures medical devices. The firm develops percutaneous circulatory assist device intended to treat chronic heart failure. Its product Aortix is a catheter deployed circulatory assist device for the millions of heart failure patients who are too sick for medication alone. The company was founded by Reynolds M. Delgado III in 2005 and is headquartered in Houston, TX. | Health Technology |
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Advanced Health Education Center Ltd.
Advanced Health Education Center Ltd. Miscellaneous Commercial ServicesCommercial Services Advanced Health Education Center Ltd. provides continuing education for healthcare professionals in the imaging sciences. The firm's services include community service and professional news, staffing, personal and elder care services and mammography. The company was founded in 1988 and is headquartered in Houston, TX. | Commercial Services |
Kardia Therapeutics, Inc.
Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Health Technology |
